DrugPatentWatch.com Basic Plan - Drug patent expirations dates, exclusivity, sales, patent detals, case histories, and more..

DrugPatentWatch - Online Approved Drug Database

This preview contains a fraction of the information available in the subscriber section and is limited to 5 results per search.

Instant Access with secure payment processing:

$195 / One Month $750 / One Year

Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Patent Expiration - 2025
Range: 1 - 5

Generic Name Tradename Applicant NDA Approval Date Type Patent Number Patent Expiration Patented / Exclusive Use
trospium chloride SANCTURA XR Indevus 022103 Aug 3, 2007 RX 7,410,978 Feb 1, 2025
cyclobenzaprine hydrochloride AMRIX Anesta 021777 Feb 1, 2007 RX 7,387,793 Feb 26, 2025
cyclobenzaprine hydrochloride AMRIX Anesta 021777 Feb 1, 2007 RX 7,387,793 Feb 26, 2025
epinephrine TWINJECT 0.15 Verus Pharms 020800 May 28, 2004 RX 7,297,136 Jan 18, 2025
epinephrine TWINJECT 0.3 Verus Pharms 020800 May 30, 2003 RX 7,297,136 Jan 18, 2025
Complete access available with subscription

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
All listed trade names are property of their owners or licensors.
Raw information from FDA Orange Book, USPTO and other sources. Copyright © 2008 thinkBiotech LLC

[ Home | Free Patent Expiration Bulletin | Pharmaceutical Innovation Dashboard | Media Access | Affiliate Program | Contact ]
Bookmark This Site

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek independent professional advice before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
All trademarks and applicant names are the property of their respective owners or licensors.